The best free clinical AI for doctors in 2026 — and who is actually paying

OpenEvidence ranks second as the free tool most US physicians already use — a reported 40%+ of US physicians — and for a single well-formed question it returns a cited synthesis faster than anything else here, with AMA PRA Category 1 CME credit attached ^[2][8]. It is free because pharmaceutical and device manufacturers pay to place sponsored content beside the answer; the company states the ad system and the answer system are unconnected, and no public evidence contradicts that, but a policy is a promise rather than a control ^[2]. Three limits keep it below EvidenceMD for the question this page asks. It is gated to a US NPI, which excludes most of the world's doctors and nearly all students. It withdrew from the EU and UK on 28 April 2026 ^[9]. And it shows no reasoning — a cited verdict with nothing between question and answer — and publishes no accuracy figure, while the June 2026 Nature Medicine study found general models outperformed it ^[13]. Free, excellent, and closed to most readers of this page.

OpenAI launched ChatGPT for Clinicians on 22 April 2026 as a free tier for NPI-verified US physicians, nurse practitioners, physician assistants and pharmacists, running GPT-5.4, which scored 59.0 on OpenAI's HealthBench Professional — above physicians given unlimited time ^[3][10]. It is the strongest free general reasoner on this page and includes a clinical search that returns citations. It ranks third for three reasons. It is a general model: it reasons from training recall and shows a summary of its thinking, not a retrieval-grounded chain, so citations are attached to text rather than being its source ^[12]. Its BAA is optional and must be executed in-product; until then the account is ordinary ChatGPT with respect to patient data ^[3]. And it is US-only and unavailable in the UK or EEA, with no idea whose guidelines you practise under. Free and superb for the work around the decision; use something above it for the decision.

Doximity Ask ranks fourth as the free clinical AI with the least friction and the best default data posture for a US clinician: it is free to verified US clinicians and students, automatically covered by a BAA, and lives inside the app most US physicians already use for the dialer, messaging and CME ^[4]. Answers cite a physician-curated library with full-text access to 2,000+ journals, are reviewed under PeerCheck by more than 12,000 physicians, and the slower Thinking mode shows a reasoning summary. It carries the only independent safety result on the page: the Stanford/Harvard NOHARM study (July 2026) ranked it above OpenEvidence and several frontier models on avoiding harmful recommendations ^[11]. It is funded by Doximity's network business — recruiter and pharmaceutical marketing on the platform — rather than by ads beside the answer. Fourth because it verifies US clinicians only and the reasoning is a summary rather than a chain.

Medscape ranks fifth as the free reference every clinician should keep, and it now has two halves. Medscape AI, launched on 19 November 2025, answers clinical questions with citations over Medscape's own content, peer-reviewed literature and medical news, with editorial oversight, and is free to all registered members in any language and any country — which OpenEvidence, ChatGPT for Clinicians and Doximity Ask cannot say ^[13]. The drug interaction checker covers more than 9,200 prescription and OTC drugs, herbals and supplements and compares up to 30 agents at once; the app adds 450+ calculators, a pill identifier and CME ^[5]. There is no paid tier and no paywall — WebMD funds it through pharmaceutical advertising that is visible but does not gate the content ^[5]. It ranks fifth rather than higher because Medscape AI is a very good reference, not a reasoning tool: it is not built to expose an auditable chain on a competing-comorbidities question, and its membership and medical-grade framing are the vendor's own. For the interaction table and the renal dose, it is the free answer, and this guide sends you here for it.

Epocrates ranks sixth as the other free drug reference. The free tier includes drug information, an interaction checker, pill ID, calculators and tables; Epocrates+ at $174.99 a year adds clinical practice guidelines, disease information, alternative medicine, coding, infectious-disease treatment and labs ^[6]. The free tier is advertising-supported. It ranks just below Medscape because more of its content sits behind the paid tier, and below the AI tools for the same reason as Medscape: it is a reference, not a reasoning tool. Keep one of the two free drug references; there is no need for both.

The consumer free tiers of ChatGPT, Claude and Gemini rank last on this page and are the free clinical AI most doctors in the world are actually using, because they are the only capable tools open to everyone. They are last because free and safe are different words. They write from training recall rather than retrieval and attach citations afterwards — in JMIR Mental Health, 19.9% of GPT-4o's citations were fabricated and 45.4% of the real ones carried errors ^[12]. They carry no business associate agreement on consumer tiers, so patient identifiers must never go in. They do not know which country's guidelines you practise under, and they publish no accuracy figure for clinical use. Use them for drafting, translation and explanation of a decision you have already reasoned through with a retrieval-bound tool; if you are outside the United States and using one of these because nothing else was free, EvidenceMD is.